MiMedx Group (MDXG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Voting matters and shareholder proposals
Election of seven directors, with each nominee recommended for approval by the board.
Advisory vote on executive compensation is presented for shareholder approval.
Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Proxies may vote on other business that may properly come before the meeting or any adjournment.
Board of directors and corporate governance
Seven director nominees are listed for election at the annual meeting.
Executive compensation and say-on-pay
Advisory approval of executive compensation is included as a voting item.
Partial view of Summaries dataset, powered by Quartr API
Latest events from MiMedx Group
- Q1 2026 sales fell 33% as wound care plunged 60% and surgical rose 13%, prompting cost cuts.MDXG
Q1 202629 Apr 2026 - Strong sales growth, new product launches, and robust governance highlighted in 2025.MDXG
Proxy filing29 Apr 2026 - Record revenue and EBITDA in 2025; surgical growth offsets wound care disruption.MDXG
Q4 20258 Apr 2026 - Strong growth, innovation, and Medicare reform position MiMedx for expanded market leadership.MDXG
TD Cowen 45th Annual Healthcare Conference3 Feb 2026 - Q2 net sales up 7.3% to $87.2M; adjusted EBITDA margin 23%; outlook remains strong.MDXG
Q2 20242 Feb 2026 - Regulatory reform, product innovation, and M&A drive growth amid reimbursement challenges.MDXG
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026 - Q3 net sales up 3% to $84M, 22% EBITDA margin, strong cash and raised guidance.MDXG
Q3 202417 Jan 2026 - New reimbursement rules and clinical innovation drive growth and market leadership.MDXG
Stifel 2024 Healthcare Conference13 Jan 2026 - Growth, innovation, and regulatory clarity drive optimism for future expansion and stability.MDXG
Cantor Global Healthcare Conference 20255 Jan 2026